Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGK1 | P00558 | 1/20 | 0.31 |
| ▸ | PGK2 | P07205 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL394722 | 0.80 | MAPK1 (0.33) | PGK1PGK2CYP3A4TSHRMAPK1 | |
| SCHEMBL120101 | 0.75 | TSHR (0.39) | PGK1PGK2CYP3A4TSHRMAPK1 | |
| SCHEMBL6379555 | 0.75 | CD44 (0.33) | CYP3A4 | |
| Formaldehyde SCHEMBL27539276 | 0.73 | MAPK1 (0.33) | PGK1PGK2CYP3A4TSHRMAPK1 | |
| SCHEMBL10346431 | 0.72 | CYP3A4 (0.37) | PGK1PGK2CYP3A4TSHRMAPK1 | |
| Fluoride SCHEMBL28587768 | 0.72 | CYP3A4 (0.37) | PGK1PGK2CYP3A4TSHRMAPK1 | |
| Hexamethylbenzene SCHEMBL10345657 | 0.72 | CYP3A4 (0.37) | PGK1PGK2CYP3A4TSHRMAPK1 | |
| SCHEMBL10411849 | 0.72 | CYP3A4 (0.37) | PGK1PGK2CYP3A4TSHRMAPK1 | |
| SCHEMBL2724509 | 0.72 | CYP3A4 (0.44) | PGK1PGK2CYP3A4TSHRMAPK1 | |
| SCHEMBL5182505 | 0.72 | CYP3A4 (0.37) | PGK1PGK2CYP3A4TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 535 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4365180-A1 | RARE EARTH COMPLEX | Tosoh Corporation (JP) | 2024-05-08 | — | — | EP | disclosed |
| CN-117616032-A | Rare earth complex | 东曹株式会社 | 2024-02-27 | — | — | CN | disclosed |
| CN-117425653-A | Method for producing bipyridine derivative, method for producing macrocyclic compound, method for producing metal complex containing macrocyclic compound as ligand, metal complex, electrode for air battery, and air battery | 住友化学株式会社 | 2024-01-19 | — | — | CN | disclosed |
| CN-112724302-B | Ethylene-alpha-olefin copolymer, process for producing the same, ethylene resin composition, and film | 住友化学株式会社 | 2023-10-31 | — | — | CN | disclosed |
| WO-2023190472-A1 | CYCLOHEXYLENEDIAMINIUM SALT, USE THEREOF, AND MSE TYPE ZEOLITE OBTAINED USING SAME | 公益財団法人相模中央化学研究所 | 2023-10-05 | — | — | WO | disclosed |
| US-11643533-B2 | Film, method of producing film, and bag | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-05-09 | — | — | US | disclosed |
| CN-111406059-B | Europium complexes | 东曹株式会社 | 2023-04-18 | — | — | CN | disclosed |
| US-20230104971-A1 | ELECTROSTATIC CHARGE IMAGE DEVELOPING TONER SET, ELECTROSTATIC CHARGE IMAGE DEVELOPER SET, AND TONER CARTRIDGE SET | FUJIFILM BUSINESS INNOVATION CORP. (JP) | 2023-04-06 | — | — | US | disclosed |
| CN-115840343-A | Toner set for electrostatic latent image development, electrostatic latent image developer set, toner cartridge set, process cartridge, image forming apparatus, and image forming method | 富士胶片商业创新有限公司 | 2023-03-24 | — | — | CN | disclosed |
| US-11581567-B2 | Lithium ion battery and electrolyte thereof | CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) | 2023-02-14 | — | — | US | disclosed |
| CN-1229093-A | Olefin polymer, olefin polymerization catalyst and process for producing olefin polymer | SUMITOMO CHEMICAL CO (JP) | 1999-09-22 | — | — | CN | disclosed |
| CN-1229096-A | Olefin polymer and process for producing the same | SUMITOMO CHEMICAL CO (JP) | 1999-09-22 | — | — | CN | disclosed |
| EP-0942010-A1 | Transition metal compounds, catalyst components and catalysts for olefin polymerization, and process for producing olefinic polymers | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1999-09-15 | — | — | EP | disclosed |
| CN-1216553-A | Olefin polymer, films or sheets made therefrom, and process for the production of olefin polymer | SUMITOMO CHEMICAL CO (JP) | 1999-05-12 | — | — | CN | disclosed |
| EP-0908435-A1 | Method for purifying transition metal compound and method for producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1999-04-14 | — | — | EP | disclosed |
| CN-1205340-A | Propylene coplymer | SUMITOMO CHEMICAL CO (JP) | 1999-01-20 | — | — | CN | disclosed |
| CN-1194650-A | Transition metal complexes, catalyst for olefin polymerization, and process for producing olefin polymers | SUMITOMO CHEMICAL CO (JP) | 1998-09-30 | — | — | CN | disclosed |
| CN-1193323-A | Transition metal complex, process for producing the same, olefin polymerization catalyst containing the transition metal complex, and process for producing olefin polymer | SUMITOMO CHEM IND (JP) | 1998-09-16 | — | — | CN | disclosed |
| EP-0852230-A1 | TRANSITION METAL COMPLEXES, CATALYST FOR OLEFIN POLYMERIZATION, AND PROCESS FOR PRODUCING OLEFIN POLYMERS | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 1998-07-08 | — | — | EP | disclosed |
| EP-0842939-A1 | TRANSITION METAL COMPLEX, PROCESS FOR THE PREPARATION THEREOF, POLYMERIZATION CATALYST FOR OLEFINS CONTAINING THE COMPLEX, AND PROCESS FOR PRODUCING OLEFIN POLYMERS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1998-05-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11581567-B2 | Lithium ion battery and electrolyte thereof | PLCB1, PLCB3, LAGE3 | PGK1 696/4885PGK2 674/4885CYP3A4 3485/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.